Cosmos Holdings
141 West Jackson Boulevard
Suite 4236
Chicago
Illinois
60604
United States
Tel: 312-536-3102
Website: http://www.cosmosholdingsinc.com
About Cosmos Holdings
Cosmos Holdings Inc. is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe.YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Dimitrios Goulielmos
20 articles about Cosmos Holdings
-
Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering
10/18/2022
Cosmos Holdings announced the pricing of its "reasonable best efforts" public offering of 62,500,000 shares of common stock, Series A Warrants to purchase 62,500,000 shares of common stock and Series B Warrant to purchase 62,500,000 shares of common stock at a combined price of $0.12 per share and warrant for aggregate gross proceeds of $7.5 million, before deducting placement agent fees and other offering expenses.
-
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
7/20/2022
Cosmos Holdings, Inc. announced that it has entered into a binding letter of intent to acquire Pharmaceutical Laboratories CANA S.A., a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies.
-
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders
6/30/2022
Cosmos Holdings, Inc. announced a strategic partnership with Cloudpharm P.C., a bio-pharmaceutical R&D company focused on the discovery of bioactive compounds with an emphasis on natural products, with the aim of developing new medicines, cosmetics and nutraceuticals.
-
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022
5/18/2022
Cosmos Holdings, Inc. provided a business update and reported financial results for the first quarter ended March 31, 2022.
-
Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee
5/3/2022
Cosmos Holdings, Inc. announced it has appointed finance veteran Dr. Anastasios Aslidis to the Board of Directors and as a member of the Board's audit committee.
-
Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021
4/19/2022
Cosmos Holdings, Inc. provided a business update and reported financial results for the year ended December 31, 2021.
-
Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
3/24/2022
Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced that it will be presenting at the Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th - 30th from 9:00 a.m. - 5:00 p.m. ET.
-
Cosmos Holdings CEO Provides Letter to Shareholders - Mar 23, 2022
3/23/2022
Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, provides the following letter to its shareholders from CEO Greg Siokas:
-
Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing
3/11/2022
Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced it will celebrate its recent listing on the Nasdaq Stock Market by ringing the Nasdaq Closing Bell in Times Square, New York City.
-
Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading on the Nasdaq
2/28/2022
Cosmos Holdings, Inc. announced the closing of a private placement offering to certain institutional investors and an insider of the Company to purchase 6,000 shares of Series A Convertible Preferred Stock and warrants to purchase 2,000,000 shares of common stock.
-
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
8/18/2021
Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European Union distribution network, announced that the Company has entered into a debt exchange agreement with its senior lender to further reduce the Company’s debt.
-
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021
8/17/2021
Cosmos Holdings, Inc., international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, provided a business update and reported financial results for the second quarter ended June 30, 2021.
-
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
7/26/2021
Cosmos Holdings, Inc. is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has further reduced the debt of the Company by converting an additional $1.25 million of related party debt personally owed to him in exchange for 208,333 shares of common stock at $6.00 per share on July 19, 2021.
-
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per ShareThe conversion price represents a premium to market
7/16/2021
Cosmos Holdings, Inc. is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has further reduced the debt of the Company by converting an additional $1.0 million of related party debt personally owed to him in exchange for 166,667 shares of common stock at $6.00 per share on July 13, 2021.
-
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria
7/8/2021
Cosmos Holdings, Inc. announced that it has entered into an exclusive distribution agreement with Mediprovita GbR to be the exclusive distributor in Germany and Austria of the Company’s Sky Premium Life, a proprietary, luxury and high-quality nutritional supplements' brand, with a complete range of vitamins, minerals, herbs and unique formulas.
-
Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board
7/1/2021
Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, announced that it has appointed finance veteran Alexi Papaconstantinou to the Company's Advisory Board.
-
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share
6/28/2021
Cosmos Holdings, Inc. is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has reduced the debt of the Company by converting $3.0 million of related party debt personally owed to him in exchange for 500,000 shares of common stock at $6.00 per share on June 25, 2021.
-
Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business
5/18/2021
Cosmos Holdings, Inc., a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, provided a business update and reported financial results for the first quarter ended March 31, 2021.
-
Cosmos Holdings Announces Third Quarter 2017 Results
11/28/2017
Cosmos Holdings announced financial results for the quarter ended September 30, 2017.
-
Cosmos Holdings Announces Second Quarter 2017 Results
8/16/2017